New Delhi, March 04 (ANI): A new method has been developed to identify splicing biomarkers for liver cancer. According to a Cold Spring Harbor Laboratory-study, researchers have developed a method for identifying splicing-based biomarkers for the most common form of liver cancer, hepatocellular carcinoma (HCC). The researchers believed the method will be useful in other cancer types as well. Since, liver cancer is particularly diverse, genetically, and prone to relapse, identifying biomarkers that can predict disease progression is an important goal. Splicing refers to a process in which an RNA message copied from information encoded in a gene is edited before it is able to serve as a blueprint for the manufacture of a specific protein.